Pharmerica (PMC) Tops Q1 EPS by 5c

Pharmerica (NYSE: PMC) reported Q1 EPS of $0.48, $0.05 better than the analyst estimate of $0.43. Revenue for the quarter came in at $511.6 million versus the consensus estimate of $500.95 million.

Pharmerica sees FY2015 EPS of $1.55-$1.65, versus the consensus of $1.62. Pharmerica sees FY2015 revenue of $1.95-2.05 billion, versus the consensus of $2.03 billion.

For earnings history and earnings-related data on Pharmerica (PMC) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• AAR agrees to buy 65% stake in MRO Holdings for $4 billion
• Prabhudas Lilladher Starts Aditya Birla Sun Life AMC (ABSLAMC:IN) at Buy (1)